Why the study?
Post-intubation hypotension is a frequent complication linked to poor outcomes, but the absence of uniform diagnostic criteria impedes the comparability of research results.
This review emphasizes the need for standardized diagnostic criteria and personalized intervention strategies to mitigate the risk of post-intubation hypotension.
May inform risk stratification during intubation; leaves open standardized hypotension definitions for comparable future research.
Research indicates that post-intubation hypotension (PIH) is the most frequent complication of intubation, potentially leading to acute myocardial infarction, renal failure, extended hospitalizations, and poor outcomes. Key physiological parameters such as age, body mass index, and baseline blood pressure are closely linked to PIH incidence. Induction drugs significantly influence the mechanisms of PIH, with varying drugs and administration methods impacting hemodynamic stability. Furthermore, the complexity of the intubation procedure exacerbates PIH by stimulating the vagus nerve and affecting cardiac output. Although current research aims to identify risk factors and physiological mechanisms of PIH, the absence of uniform diagnostic criteria impedes the comparability of results. Future studies should focus on establishing clear diagnostic standards, optimizing induction drug choices and procedural techniques, and integrating early warning indicators with personalized intervention strategies to decrease PIH incidence and enhance patient outcomes.
No takes yet. Share an insight, caveat, or question.
Pan et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: